chronic kidney disease Clinical Trials and Research
Also known as: ckd, kidney disease, renal disease, chronic renal insufficiency, esrd, kidney failure · ICD-10: N18.x
Chronic kidney disease (CKD) means your kidneys are damaged and can't filter blood properly, often worsening over time. Clinical trial research focuses on new ways to slow disease progression, manage complications, and improve patient well-being. Find a Trial helps patients search for active studies.
Search chronic kidney disease trials →
Common questions about chronic kidney disease clinical trials
What are common eligibility criteria for chronic kidney disease clinical trials?
Eligibility often depends on the CKD stage, kidney function measurements like eGFR, and the presence of specific complications. Researchers also consider age, overall health, and other medical conditions. This data helps ensure participant safety and study relevance, as seen on ClinicalTrials.gov.
What are the different phases of clinical trials for chronic kidney disease?
CKD clinical trials progress through phases, from early safety testing in a small group (Phase 1) to larger studies evaluating effectiveness and side effects (Phases 2 and 3). Phase 4 studies monitor approved treatments in wider populations. This structured approach helps ensure new treatments are safe and effective, as documented on ClinicalTrials.gov.
Do participants have to pay to join a chronic kidney disease clinical trial?
Generally, participants do not pay for study-related medical care, tests, or investigational treatments in a clinical trial. Sponsors often cover these costs. However, some trials may not cover all travel or lodging expenses. Details are always provided in the informed consent process, according to ClinicalTrials.gov.
What are current research directions for chronic kidney disease treatments?
Current research explores new medications to protect kidney function, manage blood pressure, and control anemia or bone disease related to CKD. Scientists are also investigating genetic factors and regenerative medicine approaches. This work aims to slow progression and improve quality of life, as reported by NIH RePORTER.
What types of interventions are studied in chronic kidney disease clinical trials?
Interventions include new drug therapies targeting specific pathways of kidney damage, dietary modifications, and lifestyle changes. Studies also investigate devices for monitoring or treatment, and educational programs for self-management. These diverse approaches aim to improve patient outcomes, based on data from ClinicalTrials.gov.
What biomarkers are important in chronic kidney disease research?
Key biomarkers include estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (UACR), which indicate kidney function and damage. Researchers also study novel biomarkers like kidney injury molecules (KIM-1) or neutrophil gelatinase-associated lipocalin (NGAL) to detect early damage or predict progression, according to NIH RePORTER.
What are common reasons someone might be excluded from a CKD clinical trial?
Common exclusion criteria include advanced stages of CKD requiring dialysis or transplant, uncontrolled comorbidities like severe heart disease, or certain medications that could interfere with the study drug. Pregnancy, breastfeeding, or a history of specific cancers are also often exclusions. These ensure safety and data integrity, per ClinicalTrials.gov.
How do clinical trials address quality of life for people with chronic kidney disease?
Many CKD trials include measures to assess patient-reported outcomes, such as fatigue, pain, and overall well-being. Researchers evaluate how new treatments or interventions impact daily activities and mental health. The goal is to improve not just kidney function, but also how patients feel and live, as seen on ClinicalTrials.gov.
How to find a chronic kidney disease trial that fits you
- Describe your chronic kidney disease situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all chronic kidney disease trials →